Article

Feasibility of in vivo imaging of fluorescent proteins using lifetime contrast

Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.
Optics Letters (Impact Factor: 3.18). 08/2009; 34(13):2066-8. DOI: 10.1364/OL.34.002066
Source: PubMed

ABSTRACT We show that fluorescence lifetime is a powerful contrast mechanism that can enhance the whole-body imaging of fluorescent proteins (FPs), in the presence of background tissue autofluorescence (AF). The nonexponential AF decay is characterized from time-domain (TD) measurements on multiple nude mice and separated from the FP fluorescence using a linear fit to a priori basis functions. We illustrate this approach using an orthotopic mouse tumor model of breast adenocarcinoma. We also report that four commonly used FPs show distinct lifetimes, indicating their suitability for in vivo lifetime multiplexing. These results suggest the potential for exploiting fluorescence lifetime for imaging FPs for a variety of whole-body small-animal imaging applications.

Download full-text

Full-text

Available from: Jeroen A.J.M. Van de Water, Aug 19, 2015
0 Followers
 · 
136 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent advances in laser technology, computational power, and imaging algorithms have extended the application of fluorescence lifetime method into medical imaging. Initial applications of fluorescence lifetime in cell studies focused on autofluorescence lifetimes of endogenous fluorophores. The lifetime signatures of these biomolecules can be altered by changes in normal cell physiology or pathologic conditions. Scientists have accelerated the development of new fluorophores and luminescent materials for lifetime studies. Depending on the ultimate goal of the study, molecular probes with fixed or variable lifetimes can be used. The availability of a commercial small animal imaging system has extended the application of fluorescence lifetime studies in small animal beyond the confines of instrumentation experts. The emergence of newer diffuse optical tomography (DOT)-based lifetime devices will further enhance the quantitative accuracy and imaging depth by this technique.
    Chemical Reviews 03/2010; 110(5):2641-84. DOI:10.1021/cr900343z · 45.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Near-infrared (NIR) fluorescence tomography of multiple fluorophores has previously been limited by the bandwidth of the NIR spectral regime and the broad emission spectra of most NIR fluorophores. We describe in vivo tomography of three spectrally overlapping fluorophores using fluorescence lifetime-based separation. Time-domain images are acquired using a voltage-gated, intensified charge-coupled device (CCD) in free-space transmission geometry with 750 nm Ti:sapphire laser excitation. Lifetime components are fit from the asymptotic portion of fluorescence decay curve and reconstructed separately with a lifetime-adjusted forward model. We use this system to test the in vivo lifetime multiplexing suitability of commercially available fluorophores, and demonstrate lifetime multiplexing in solution mixtures and in nude mice. All of the fluorophores tested exhibit nearly monoexponential decays, with narrow in vivo lifetime distributions suitable for lifetime multiplexing. Quantitative separation of two fluorophores with lifetimes of 1.1 and 1.37 ns is demonstrated for relative concentrations of 1:5. Finally, we demonstrate tomographic imaging of two and three fluorophores in nude mice with fluorophores that localize to distinct organ systems. This technique should be widely applicable to imaging multiple NIR fluorophores in 3-D.
    Journal of Biomedical Optics 07/2010; 15(4):046011. DOI:10.1117/1.3469797 · 2.75 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Herein we discuss how FRET imaging can contribute at various stages to delineate the function of the proteome. Therefore, we briefly describe FRET imaging techniques, the selection of suitable FRET pairs and potential caveats. Furthermore, we discuss state-of-the-art FRET-based screening approaches (underpinned by protein interaction network analysis using computational biology) and preclinical intravital FRET-imaging techniques that can be used for functional validation of candidate hits (nodes and edges) from the network screen, as well as measurement of the efficacy of perturbing these nodes/edges by short hairpin RNA (shRNA) and/or small molecule-based approaches.
    ChemPhysChem 02/2011; 12(3):442-61. DOI:10.1002/cphc.201000866 · 3.36 Impact Factor
Show more